Mycobacterial disease in a population of 339 cats in Great Britain: II. Histopathology of 225 cases, and treatment and outcome of 184 cases

This study investigated 339 cases of feline mycobacterial infection, with histopathology findings from 225 cases, and treatment and outcome information from 184 cases. Tissue samples from cats with cutaneous lesions or suspicious masses at exploratory laparotomy were submitted to the Veterinary Laboratories Agency for mycobacterial culture over a 4-year period to December 2008. The study reviewed the files for information about histopathology, treatment and outcome, and blindly reviewed histopathological changes (including staining for acid-fast bacteria [AFB]) in a sub-set of 45 cases. When a cat is suspected of having a mycobacterial infection, accurate identification of the species involved helps to determine possible treatment options and prognosis. The study confirmed that histopathology and the presence of AFB are useful tools in the recognition of mycobacterial infection. Unfortunately, they did little to help determine the species of mycobacteria involved. The study identified a group of cats that were negative for AFB at the primary laboratory, but from which mycobacteria could be cultured; commonly Mycobacterium bovis or Mycobacterium microti. The study also identified a group of cats which where culture negative, despite typical signs of mycobacterial infection and positive AFB staining. Many cases responded favourably to treatment (56% of the cases where information was available), and many cats gained complete remission (42%). However, relapses were common (64%) and often followed by pulmonary and/or systemic spread that may have resulted from treatment with short courses of single drugs. This study shows that the diagnosis and treatment of feline mycobacteriosis is complex and challenging.     

Spatial and temporal investigation of Echinococcus granulosus coproantigen prevalence in farm dogs in South Powys, Wales

The prevalence of canine echinococcosis appears to have been increasing in mid/south Wales in recent years - raising the concern of a potential resurgence in transmission to humans. A campaign was therefore conducted in 2008 in order to provide dogs in South Powys with anthelmintics, estimate the coproantigen prevalence amongst these dogs, and evaluate potential risk factors for coproantigen positivity. The coproantigen prevalence identified in these dogs (n=577) was 10.6% (95% confidence interval 7.6-13.5%), with 20.6% (15.6-25.7%) of farms (n=247) containing at least one coproantigen-positive dog. Further spatial investigation identified considerable spatial heterogeneity amongst the farms, with an increased coproantigen prevalence in the regions of Brecknockshire and the Brecon Beacons National Park. Within these areas, there was strong evidence of an increase in coproantigen prevalence, compared to that found in a study conducted in 2002. Finally, a mixed effects logistic regression model identified increased roaming behaviour and decreased dog weight as being associated with increased odds of coproantigen positivity, whereas pet dogs on some farms had similar odds of infection to working dogs. Further surveillance efforts in South Powys are required and should also include the northern areas of Gwent and Glamorgan.     

Influence of imidacloprid seed treatments on rice germination and early seedling growth

BACKGROUND: Seed treatments with the chloronicotinyl insecticide imidacloprid (Gaucho 600 FS) were evaluated to determine whether differences in concentration and exposure regime influence the germination and early growth of rice. RESULTS: Continuous exposure to imidacloprid (4 days at 2000 mg AI L(-1)) significantly (P < 0.001) reduced normal germination by an average of 18% across the 15 cultivars examined. Nine days after sowing, plants showed no adverse effects from continuous imidacloprid treatment during germination, with shoot lengths and root system dry weights equalling, or occasionally exceeding (P < 0.05), those of untreated plants. Short-term imidacloprid exposure (2 h at 2000 mg L(-1)) at initial seed wetting did not affect germination (P > 0.05), and short-term (1 h) exposure of 48 h pregerminated seed to imidacloprid (2000 mg L(-1)) similarly had no significant effect on early subsequent growth. Plants arising from 48 h pregerminated seed exposed to imidacloprid (1 h) at concentrations up to 4000 mg L(-1) immediately before sowing were not significantly different from control plants at either 9 or 25 days post-sowing. CONCLUSION: Results show that imidacloprid will have no adverse effects on plant growth if applied to pregerminated rice shortly before sowing. Continuous exposure of seed during germination had more pronounced effects, and the initial response of different cultivars was highly variable. Cultivars with high levels of sensitivity (such as IR72) require further testing before continuous exposure to imidacloprid during germination can be recommended.     

Pharmacokinetics of morphine and its metabolites in freshwater rainbow trout (Oncorhynchus mykiss)

In this study, we injected morphine sulfate IP into rainbow trout and measured the concentration of morphine and all potential metabolites in plasma using LC-MS/MS at a series of times after the injection. The pharmacokinetics of morphine were similar to those previously reported for seawater-acclimated rainbow trout, i.e. they were about one order of magnitude slower than in similarly sized mammals. The only metabolite of morphine present in the plasma was morphine-3-β- d -glucuronide (M3G); morphine-6-β- d -glucuronide (M6G) was not detected. M3G gradually increased after the morphine injection, peaked about 2 days later, then gradually decreased. In mammals, M3G plasma levels exceed morphine levels extremely rapidly, i.e. in less than an hour, regardless of dose, route of administration, or species. In trout, it took 2 days for M3G levels to exceed morphine levels. This is the first study of the metabolites of morphine in any ectotherm. We conclude that trout can metabolize morphine, but at a rate much slower than in mammals.     

Assessment and monitoring of soil quality using near-infrared reflectance spectroscopy (NIRS)

Soil degradation processes have dramatically increased in their extent and intensity over the last decades. Progressively, actions have been taken in order to evaluate and reduce the major threats that have already wreaked havoc on soil conditions. Efficient and standardized monitoring of soil conditions is thus required but soil quality research is facing an important technological challenge because of the number of properties involved in soil quality. The objective of the present review is to examine critically the suitability of near-infrared reflectance spectroscopy (NIRS) as a tool for soil quality assessment. We first detail the soil quality-related parameters (chemical, physical and biological) that can be predicted with NIRS through laboratory measurements. The ability of imaging NIRS (airborne or satellite) for mapping a minimum data set of soil quality is also discussed. Then we review the most recent research using soil reflectance spectra as an integrated measure of soil quality, from global site classification to the prediction of specific soil quality indices. We conclude that imaging NIRS enables the direct mapping of some soil properties and soil threats, but that further developments to solve several technological limitations identified are needed before it can be used for soil quality assessment. The robustness of laboratory NIRS for soil quality assessment allows its implementation in soil monitoring networks. However, its routine use requires the development of international soil spectral libraries that should become a priority for soil quality research.     

Crystal structure of a lipid G protein-coupled receptor

The lyso-phospholipid sphingosine 1-phosphate modulates lymphocyte trafficking, endothelial development and integrity, heart rate, and vascular tone and maturation by activating G protein-coupled sphingosine 1-phosphate receptors. Here, we present the crystal structure of the sphingosine 1-phosphate receptor 1 fused to T4-lysozyme (S1P(1)-T4L) in complex with an antagonist sphingolipid mimic. Extracellular access to the binding pocket is occluded by the amino terminus and extracellular loops of the receptor. Access is gained by ligands entering laterally between helices I and VII within the transmembrane region of the receptor. This structure, along with mutagenesis, agonist structure-activity relationship data, and modeling, provides a detailed view of the molecular recognition and requirement for hydrophobic volume that activates S1P(1), resulting in the modulation of immune and stromal cell responses.